BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eby JM, Abdelkarim H, Albee LJ, Tripathi A, Gao X, Volkman BF, Gaponenko V, Majetschak M. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists. Mol Cell Biochem 2017;434:143-51. [PMID: 28455789 DOI: 10.1007/s11010-017-3044-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Singh KD, Jara ZP, Harford T, Saha PP, Pardhi TR, Desnoyer R, Karnik SS. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers. Proc Natl Acad Sci U S A 2021;118:e2019126118. [PMID: 34380734 DOI: 10.1073/pnas.2019126118] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Gao X, Enten GA, DeSantis AJ, Majetschak M. Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers. FEBS Lett 2021;595:1863-75. [PMID: 34032285 DOI: 10.1002/1873-3468.14135] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Gao X, Cheng YH, Enten GA, DeSantis AJ, Gaponenko V, Majetschak M. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. J Biol Chem 2020;295:14893-905. [PMID: 32839271 DOI: 10.1074/jbc.RA120.015355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
4 Babu FS, Liang X, Enten GA, DeSantis AJ, Volkman BF, Gao X, Majetschak M. Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage. Sci Rep 2020;10:11359. [PMID: 32647374 DOI: 10.1038/s41598-020-68425-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 De Clercq E. Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. Antivir Chem Chemother 2019;27:2040206619829382. [PMID: 30776910 DOI: 10.1177/2040206619829382] [Cited by in Crossref: 49] [Cited by in F6Publishing: 61] [Article Influence: 16.3] [Reference Citation Analysis]
6 Kenakin T, Barker EL. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev 2019;71:267-315. [DOI: 10.1124/pr.118.016790] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 30.3] [Reference Citation Analysis]
7 Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. Open Biol 2018;8:170207. [PMID: 29386406 DOI: 10.1098/rsob.170207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
8 Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. PLoS One 2018;13:e0204041. [PMID: 30248140 DOI: 10.1371/journal.pone.0204041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lüke F, Blazquez R, Yamaci RF, Lu X, Pregler B, Hannus S, Menhart K, Hellwig D, Wester HJ, Kropf S, Heudobler D, Grosse J, Moosbauer J, Hutterer M, Hau P, Riemenschneider MJ, Bayerlová M, Bleckmann A, Polzer B, Beißbarth T, Klein CA, Pukrop T. Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment. Oncotarget 2018;9:18844-57. [PMID: 29721166 DOI: 10.18632/oncotarget.24787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Gao X, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex. Sci Rep 2018;8:2730. [PMID: 29426850 DOI: 10.1038/s41598-018-21096-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
11 Cheng YH, Eby JM, LaPorte HM, Volkman BF, Majetschak M. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. PLoS One 2017;12:e0187949. [PMID: 29125867 DOI: 10.1371/journal.pone.0187949] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]